Skip to main content
Equibles
PCSA logo

PCSA · Processa Pharmaceuticals, Inc. · Webcasts, Transcripts & Audio

Track PCSA — free

Use PCSA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PCSA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.49 +0.00 (+0.00%)
Rebalance outlook locked
Going-concern doubt — cleared Aug 14, 2026

The latest filing states the doubt was alleviated.

“Following our acquisition of Vidya and closing of the related $200 million gross private placement (from which we received net proceeds of $183.3 million) on July 30, 2026, we believe our cash and cash equivalents will be sufficient to satisfy our cash requirements over the next 12 months and beyond. This represents a material change from what we reported in our 2025 Form 10-K that disclosed substantial doubt of our ability to continue as a going concern.”
View the 10-Q filed Aug 14, 2026
Market Cap
$5.14M
Shares
2.79M
Volume · Oct 6 16.93K Avg daily vol (3M) 223.63K

Processa Pharmaceuticals, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Processa Pharmaceuticals, Inc. (PCSA), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →
Conference
Investor event
2026-09-11
Processa Pharmaceuticals, Inc. (PCSA) September 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY22 · Q4
2023-03-31
Processa Pharmaceuticals, Inc. (PCSA) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Processa Pharmaceuticals, Inc. (PCSA) Q3 2022 Earnings Call Transcript
Diluted EPS
$-185.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-12
Processa Pharmaceuticals, Inc. (PCSA) Q2 2022 Earnings Call Transcript
Diluted EPS
$-160.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
Processa Pharmaceuticals, Inc. (PCSA) Q1 2022 Earnings Call Transcript
Revenue
$
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
Processa Pharmaceuticals, Inc. (PCSA) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-09-30
Processa Pharmaceuticals, Inc. (PCSA) Q3 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-13
Processa Pharmaceuticals, Inc. (PCSA) Q2 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
Processa Pharmaceuticals, Inc. (PCSA) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-25
Processa Pharmaceuticals, Inc. (PCSA) Q4 2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–10 of 10 webcasts
Key facts CIK 1533743 CUSIP 74275C403 Visit website Investor relations